Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
15 skywatching events you won't want to miss in 2026 - 2Plans for ‘stop anywhere’ night buses recommended by government for women’s safety
- 3Czech Republic's new premier: No money for Ukraine
- 4Knesset sets special panel to fast-track Karhi’s communications reform
- 5Bronze Age "City of Seven Ravines" unearthed in central Asia after 3,500 years
- These Are the Journalists Israel Has Killed Since the Start of the Iran War
- An Extended time of Careful Nurturing: Individual Bits of knowledge on Bringing up Kids
- Vote In favor of Your Favored Comupter Game
- I read 115 books this year. 'Wuthering Heights,' 'Heart the Lover' and 'The House of My Mother' were among my 10 favorites.
- In wrangling dark matter, some scientists find inspiration in the Torah, Krishna and Christ
- Instructions to Pick the Best Album Rates for Your Investment funds
- Doctors say changes to US vaccine recommendations are confusing parents and could harm kids
- Ukraine demands army of 800,000 under peace plan
- An eye for an eye: People agree about the values of body parts across cultures and eras
